Thank you, Debbie, and good afternoon, everybody. Thanks for tuning into our call. We're going to talk about second quarter results obviously, dig into some specifics of the recent refinance efforts, or refinance process that we went through earlier in July, and close the call by talking through our expectations for the remainder of 2024. So, long story short, we feel that the second quarter was a very good quarter for Astronics. Simply put, strong sales, improving margins and very strong bookings. Our Aerospace segment, which is just shy of 90% of our sales year-to-date had a very good quarter. Our Test segment, approximately 10% of our sales had what I would term as a reset quarter. We'll get into the segment results a little bit later, but as I already mentioned, we also, after the quarter close, accomplished a refinance in early July, which we feel is a very important step forward for the financial health of our company. Running through some overall consolidated numbers, again, sales of $198 million exceeded our guidance for the quarter. That's happened a handful of times recently, has become a little bit of a trend. Up 14% year-over-year in the comparator quarter and up 7% sequentially from the first quarter. The sales level marks a return, frankly, to pre-pandemic levels. The sales level was enabled by positive trends that continue to propel us forward. And these are things that we talked about the last few calls. I'm not going to go into them a whole lot of detail, but we continue to see moderating inflation. We continue to see price increases that we have implemented taking hold and beginning to have an effect on our business. And most importantly, our supply chain, which is very much global in nature, continues to improve. Also, our workforce turnover has reduced from the very high levels of 2022 and 2023, and the efficiency of our workforce is improving, and I expect will continue to improve. A tidbit of number which may surprise you, it did me when we ran these numbers, our workforce currently totals about 2,600 people and 43% of them at the end of the second quarter had been with us for less than three years. That's almost half, and it's a much higher percentage than what we are typically accustomed to. I don't think it's unique. I think a lot of companies in our space are dealing with the same realities, and it makes it challenging to step on the gas and immediately have a response in terms of organizational efficiency. But we're getting better and it's starting to show in our financials. The income statement is improving with the sales level. Dave will talk through a lot of the details in just a few minutes. The adjusted EBITDA for the quarter was 10.2%, up from 9.1% last year or $20.2 million compared to $15.9 million. That's an improvement, but we expect more of it as we go through the year as our sales continue to climb and as our supply chain continues to improve and as our workforce efficiency and quality improves, and as price increases continue to take hold. Also, and it shouldn't be understated, demand continues to be very strong. Our second quarter bookings were $219 million. That's a book-to-bill of 1.11, and it was strong demand really across our range of product lines. It's really nice when you have a high shipping quarter and an even higher booking quarter that makes you feel really confident about the near-term future of the business. Our 12-month bookings at the end of the second quarter were $783 million. That again is a number that's approaching pre-pandemic levels. And we ended the quarter with a record backlog again of $633 million, with importantly $402 million scheduled to ship in the second half of 2024. Looking at our segments, simply put, again aerospace, our Aerospace segment had a really nice quarter. It's 90% of our consolidated sales. And basically, as Aerospace goes, Astronics goes. Solid growth of 11.7% year-over-year, $177 million in revenue with good margin improvement. Dave will talk through those details in a second. I want to spend a few minutes talking about Test and what I described earlier as a reset quarter. We had a restructuring in April that I think we talked about on our first quarter call, and it was designed to save about $4 million annually beginning in the current quarter, the third quarter of 2024. So that restructuring was accomplished. And as part of that, we closed a facility in Texas, a smaller one, about 30 people or so, and consolidated those results in our Orlando headquarters. It's similar to a consolidation we implemented last year of an operation up in the Boston area and another one that we have announced but not yet accomplished for a smaller U.K. operation. All of these are designed to simplify the business, simplify the operations, and lower costs, and we're well underway with that effort. An unfortunate development in the second quarter was an estimate to complete adjustment of $3.5 million for a couple of revenue over time or otherwise people might know it as a percentage of completion jobs in our transit test business. These resulted in sales and margin reductions of $3.5 million in the quarter, and it's basically a result of doing a ground-up review of those programs and learning or deciding or discovering that we weren't as far along in terms of a development effort as we thought we were. We should get that revenue back over the next few quarters. The contribution on it is something we're going to have to wait and see what that's all about. But that was a negative development for our Test business, but we feel sets us up pretty good for the second half of the year getting it behind us. Most importantly, in the second quarter we were finally awarded that radio test contract by the U.S. Army that you've heard me talk about almost for two years now. It was an IDIQ or indefinite delivery, indefinite quantity contract for radio test equipment that is designed to allow the U.S. Army to test its full range of radios proactively and to diagnose failures in the field or in the lab or wherever. It is a big program. It's funded to be $215 million. We understand that there's clearly demand in the field at the Army to consume that amount of money, and we expect that it will be consumed in the coming years. The initial contract came with an award for $15.5 million and $7.2 million of that was recognized as revenue in the second quarter. We expect the majority of the remainder, a total of about $10 million to $12 million, will be recognized over the course of 2024. And that initial delivery order was for engineering, qualification and low-rate initial production tests. The question remains, when will full rate production begin? And we don't know the answer to that yet. We have some tests we need to get through as part of the initial LRIP award. We also are dependent on the Army getting through some of their tests. Our best guess is that it's mid-2025 or later, but probably will be commenced by the early part of 2026. More on that as it happens over the coming months. For that program, along with the cost reductions that we've implemented, we expect we'll put the test business on a much better footing compared to where it's been over the last quarter, last few quarters. Finally, the refinance that we announced early in July. This is a big deal for our company. It is basically a larger improved ABL revolver facility combined with a reduced less expensive term loan and the combination of the two in sum provides us a lower combined interest rate, much lower amortization compared to what we had before, an improved level of available liquidity, and friendlier covenants. In sum, it's an important step towards the recovery of our company and gives us the flexibility financially to make the investments we need to make to realize the opportunities that are ahead of us in the near future. I'll turn it over to Dave at this point to talk through some of the details of the quarter and the refinance package. Dave?